Search Results - "de la Morena, P."

116P RETROSPECTIVE ANALYSIS OF PATIENTS WITH THYMIC MALIGNANCIES TREATED AT THE VALL D'HEBRON UNIVERSITY HOSPITAL by Martínez, P, Declara, I. Macías, Martinez-Marti, A, Cedres, S, Navarro, A, Fico, M, De la Morena, P, Salcedo, M.T, Romero, L, Felip, E

Get full text

A prognostic model to identify short survival expectancy of medical oncology patients at the time of hospital discharge by Vicente Conesa, M.A., Zafra Poves, M., Carmona-Bayonas, A., Ballester Navarro, I., de la Morena Barrio, P., Ivars Rubio, A., Montenegro Luis, S., García Garre, E., Vicente, V., Ayala de la Peña, F.

“…Hospitalization of cancer patients is associated with poor overall survival, but prognostic misclassification may lead to suboptimal therapeutic decisions and…”
Get full text

317P Survival analysis and prognostic factors in patients with metastatic breast cancer and oligometastatic disease by Marin Zafra, G., Torralba, E.G., Garcia, V., de la Morena, P., Martinez Ortiz, M.J., Garcia, E., Ivars, A., Alvarez Abril, B., Sánchez Cánovas, M., Garcia Martinez, E., Ayala de la Peña, F.

Get full text

Abstract P6-17-31: Real world evidence of neoadjuvant treatment based on dual blockade with pertuzumab plus trastuzumab for early HER2+ breast cancer: The NeoPETRA study by Chacón, JI, Saura, C, Ciruelos, E, Alonso, JI, de la Morena, P, Santisteban Eslava, M, Gallegos, I, de Luna, A, Dalmau, E, González-Santiago, S

“…Background: Evidence from clinical trials supports the neoadjuvant use of pertuzumab and trastuzumab with chemotherapy to improve the pathologic complete…”
Get full text

1405PA PROGNOSTIC MODEL OF SURVIVAL AFTER FIRST HOSPITAL DISCHARGE OF CANCER PATIENTS by Conesa, M.A. Vicente, Fernanadez, A., Zafra, M., Barrio, P. De La Morena, Ballester, I., Garcia-Garre, E., Urrgeo, E., Carmona-Bayonas, A., Peña, F. Ayala de La

“…Abstract Aim: Unplanned hospitalization of cancer patients has been associated to low survival. Although prognostic tools exist for palliative patients, no…”
Get full text

Abstract P5-01-08: Changes induced by neoadjuvant chemotherapy (NCT) in breast cancer tumor infiltrating lymphocytes (TIL) subpopulations are associated with chemo-sensitivity and prognosis by García-Martínez, E, Luengo-Gil, G, Chaves, A, Gonzalez-Billalabeitia, E, García, García T, Vicente Conesa, MA, García Garre, E, de la Morena, P, Vicente, V, Ayala de la Peña, F

“…Background: Recent data support the modulation of immune response in breast cancer microenvironment by neoadjuvant chemotherapy. This immune modulation might…”
Get full text

Abstract P5-11-05: Concordance of genomic alterations with targeted sequencing of circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) in endocrine-resistant metastatic breast cancer by Ayala de la Peña, F, Navarro Manzano, E, Fernández Pérez, MP, García Martínez, E, de la Morena Barrio, P, Ivars Rubio, A, González Billalabeitia, E, Fernández Sánchez, A, Teruel Montoya, R, Marín Zafra, G

“…Background: Liquid biopsy has emerged as a valuable strategy for analyzing resistance biomarkers in advanced breast cancer. Differences in genomic alterations…”
Get full text

Neutrophil-lymphocyte ratio (NLR) as a prognostic factor in metastatic breast cancer by Ayala de la Peña, F., Yufera Soler, J.C., Ivars, M.A., Fernandez Sanchez, A., Navarro Manzano, E., De la Morena Barrio, P., Garcia-Garre, E., Garcia-Martinez, E., Marin Zafra, G., Salguero Aguilar, R., Garcia, T.

Get full text

Abstract P5-15-09: Evaluation of growth modulation index as a marker of benefit for consecutive lines of treatment for metastatic breast cancer by Ayala de la Peña, F, Ivars Rubio, A, de la Morena Barrio, P, Fernández Sánchez, A, Luengo Gil, G, García Martínez, E, García Garre, E, Marín Zafra, G, Vicente, V

“…Background: Sequencing of single-agent chemotherapy (CT) is the current standard of treatment for endocrine-resistant metastatic breast cancer (MBC). However,…”
Get full text

Adrenalectomía laparoscópica por patología maligna by Vega Vega, A., Canga Presa, J.M., Sanz de la Morena, P., Cruz Vigo, J.L. de la

Get full text

Laparoscopic adrenalectomy in adrenal carcinoma by Vega Vega, A, Canga Presa, J M, Sanz de la Morena, P, de la Cruz Vigo, J L

“…There is general agreement on the suitability of the laparoscopic approach for benign adrenal lesions against open procedures because of the efficacy and less…”
Get full text

Adrenalectomía laparoscópica por patología maligna by Vega Vega, A., Canga Presa, J.M., Sanz de la Morena, P., de la Cruz Vigo, J.L.

“…Existe un consenso generalizado de las bondades de la adrenalectomía laparoscópica respecto a la cirugía abierta en la patología benigna de suprarrenal, por su…”
Get full text

Enfermedad de Paget de la mama en un varón de 96 años by del Burgo Fernández, J.L., Ruiz Serrano, A., Martí de la Morena, P., Al-Lach Mohamed, A.

Get full text